SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Abgenix, Inc. (ABGX)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: fred hayes who wrote (367)9/17/2004 5:24:55 AM
From: Icebrg   of 590
 
Fred, my comment was made in the light of the expense rate at which Abgenix presently is running its operations. Over the last 12 months they expensed about 150 mUSD. So, while 50 mUSD a year is a substantial amount of money, the bottom line will still remain very red.

Not that I understand how they can have such a high level of costs, considering that there is only one late-stage product for which they even carry only half the cost.

Erik
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News